Watch the latest installment of our video series!
Lina T Arango, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).
Optometrists reflect on their residency experiences and provide advice to current residents.
This imaging technique provides depth-resolved images of retinal vasculature.
Lorraine Provencher, MD, reviews the NOVA trial which measured and validated the sensitivity of a novel VR-based wearable headset for visual field testing in glaucoma.
John Buch, OD, MS, with JJV, shares an update on the company's HEV filter contact lens.
Avoid color-scheme bias and vet all data before making treatment decisions
Denise A. Valenti, OD, FAAO, gives key takeaways from her AAOpt 2022 discussion on the impact of marijuana use and driving.
How to tailor an eye examination and what technology to consider.
David Liao, MD, shares highlights from his discussion on evolving treatment strategies for neovascular AMD and DME, during the 17th annual Controversies in Modern Eye Care meeting.
The new device from Lumenis aids in ocular surface disease treatment by combining radio frequency and dynamic muscle stimulation to improve lower lid laxity, enhance blink dynamics, and offer a non-invasive solution for dry eye management.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Medical and surgical technological advances show promise for future glaucoma management.
Clinical pilot study evaluates effect after 1 month of wear.
Dina Erickson, OD, FAAO, caught up with Peg Achenbach, OD, FAAO, while at the 2023 Victoria Conference to share highlights from her talk on glaucoma suspects.
Understand the condition’s structural, innervational, neurological, and genetic abnormalities
The expenditure of embracing new technologies is worthwhile.
Pathogenesis and detection of diabetic retinopathy.
Medical and surgical technological advances show promise for future glaucoma management.
Pediatric TINU syndrome is rare, but responds well to treatment.
Considering recovery time, potential adverse effects, and future eye care needs can increase patient satisfaction.
Visual acuity remains an important indication of ocular and visual health.
Alexis G. Malkin, OD, FAAO, and Anita Gulmiri, OD, FAAO, share highlights from their presentation, "Intersection of low vision and contact lens: unique examples of co-management," which they presented during AAOpt 2022.
Technologies that improve treatment of ONHD and similar pathologies.
ODs have the rare opportunity to engage as well as educate patients on hypertension.
Building confidence and knowledge can reduce office visits and increase results.
Harmin Chima, OD, met with Optometry Times to discuss treatment options for ocular surface disease with Biovance's 3-layer amniotic membrane graft.